CNS Pharmaceuticals CNSP
NASDAQ CNSP
$5.32 +0.08 (+1.53%)
At close: Oct 2, 2026 · 4:00 PM EDT

CNS Pharmaceuticals (CNSP) Return on Capital Employed [ROCE] (2019 - 2025)

Updated

CNS Pharmaceuticals (CNSP) recorded Return on Capital Employed [ROCE] of -260.14% in Q4 2025, up 9.30 percentage points from -269.44% a year earlier but down 142.58 percentage points from the prior quarter.

Analysis

CNS Pharmaceuticals (CNSP) Return on Capital Employed [ROCE] (2019 - 2025) Analysis & Trends

For FY2025, CNS Pharmaceuticals reported Return on Capital Employed [ROCE] of -350.48%, up 206.27 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of -255.72 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -556.76% in FY2024 (+959.71 pp), -1516.47% in FY2023 (-1261.38 pp), -255.09% in FY2022 (-105.92 pp) and -149.17% in FY2021 (-54.41 pp).
  • Quarterly Return on Capital Employed [ROCE] has ranged from -5800.22% in Q3 2023 to -88.08% in Q1 2021 over the past five years.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 3864.32 percentage points in Q3 2024, against a drop of 5663.63 percentage points in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at -117.55% (Q3 2025), -122.21% (Q2 2025) and -185.83% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 CNS Pharmaceuticals 2.36 Mn -39.88 Mn - -260.14%
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -260.14%
Sep 30, 2025 -117.55%
Jun 30, 2025 -122.21%
Mar 31, 2025 -185.83%
Dec 31, 2024 -269.44%
Sep 30, 2024 -1,935.90%
Sep 30, 2023 -5,800.22%
Jun 30, 2023 -596.23%
Mar 31, 2023 -270.07%
Dec 31, 2022 -237.61%
Sep 30, 2022 -136.60%
Jun 30, 2022 -104.10%
Mar 31, 2022 -124.72%
Dec 31, 2021 -192.17%
Sep 30, 2021 -136.03%
Jun 30, 2021 -104.83%
Mar 31, 2021 -88.08%
Dec 31, 2020 -125.83%
Sep 30, 2020 -301.76%
Jun 30, 2020 -158.45%
API Access

CNS Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CNSP&period=max&api_key=YOUR_API_KEY